Mirae Asset Securities »

Cytokinetics shares owned by Mirae Asset Securities

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Mirae Asset Securities from 13F filings

Historical chart of Mirae Asset Securities investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Mirae Asset Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Mirae Asset Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.8M 60k 63.54

More positions owned by Mirae Asset Securities

Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Iren Ordinary Shares (IREN)
Amazon (AMZN)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Advanced Micro Devices (AMD)
Spdr Series Trust State Street Spd (XRT)
Apple (AAPL)
Select Sector Spdr Tr State Street Ind (XLI)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)

View all positions for Mirae Asset Securities

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
State Street Corporation
Deep Track Capital
Geode Capital Management
Susquehanna International
Rtw Investments
Goldman Sachs Group
Polar Capital Holdings
Armistice Capital
Integral Health Asset Management
Citadel Advisors

View all funds holding Cytokinetics